Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.

de Fallois J, Baatz S, Krüger BM, Dilz LM, Boldt A, Beck J, Bornemann-Kolatzki K, Petzold F, Daniel C, Amann K, Kowald J

Open source

DOI: 10.3389/fimmu.2026.1867833
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1867833,
  title = {Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.},
  author = {de Fallois J and Baatz S and Krüger BM and Dilz LM and Boldt A and Beck J and Bornemann-Kolatzki K and Petzold F and Daniel C and Amann K and Kowald J},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1867833},
  url = {https://doi.org/10.3389/fimmu.2026.1867833}
}

RIS

TY  - JOUR
TI  - Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.
AU  - de Fallois J
AU  - Baatz S
AU  - Krüger BM
AU  - Dilz LM
AU  - Boldt A
AU  - Beck J
AU  - Bornemann-Kolatzki K
AU  - Petzold F
AU  - Daniel C
AU  - Amann K
AU  - Kowald J
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1867833
UR  - https://doi.org/10.3389/fimmu.2026.1867833
ER  -

APA

J, D. F., S, B., BM, K., LM, D., A, B., J, B., K, B., F, P., C, D., K, A., & J, K. (2026). Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1867833

Source records

pubmed · retrieved 2026-09-26T04:22:07.595Z